Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 184

1.

The clinical and histological features of transitional cell carcinoma of the bladder with microcysts: analysis of 12 cases.

Paz A, Rath-Wolfson L, Lask D, Koren R, Manes A, Mukamel E, Gal R.

Br J Urol. 1997 May;79(5):722-5.

PMID:
9158509
2.

The significance of tumour grade in predicting disease progression in stage Ta transitional cell carcinoma of the urinary bladder.

Chen SS, Chen KK, Lin AT, Chang YH, Wu HH, Hsu TH, Chang LS.

Br J Urol. 1996 Aug;78(2):209-12.

PMID:
8813915
3.

Micropapillary variant of transitional cell carcinoma of the urinary bladder. Histologic pattern resembling ovarian papillary serous carcinoma.

Amin MB, Ro JY, el-Sharkawy T, Lee KM, Troncoso P, Silva EG, Ordóñez NG, Ayala AG.

Am J Surg Pathol. 1994 Dec;18(12):1224-32.

PMID:
7977945
4.
5.

Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases.

Ro JY, Shen SS, Lee HI, Hong EK, Lee YH, Cho NH, Jung SJ, Choi YJ, Ayala AG.

Am J Surg Pathol. 2008 May;32(5):752-7. doi: 10.1097/PAS.0b013e318159af9e.

PMID:
18379419
6.
7.

Low-dose BCG instillations in the treatment of stage T1 grade 3 bladder tumours: recurrence, progression and success.

Lebret T, Gaudez F, Hervé JM, Barré P, Lugagne PM, Botto H.

Eur Urol. 1998;34(1):67-72.

PMID:
9676417
8.

Prostate stem cell antigen predicts tumour recurrence in superficial transitional cell carcinoma of the urinary bladder.

Elsamman E, Fukumori T, Kasai T, Nakatsuji H, Nishitani MA, Toida K, Ali N, Kanayama HO.

BJU Int. 2006 Jun;97(6):1202-7.

9.

Bladder cancer in Sri Lanka: experience from a tertiary referral center.

Goonewardena SA, De Silva WA, De Silva MV.

Int J Urol. 2004 Nov;11(11):969-72.

10.

A population-based study of 538 patients with newly detected urinary bladder neoplasms followed during 5 years.

Larsson P, Wijkström H, Thorstenson A, Adolfsson J, Norming U, Wiklund P, Onelöv E, Steineck G.

Scand J Urol Nephrol. 2003;37(3):195-201.

PMID:
12775276
11.

Clinical outcome of conservative therapy for stage T1, grade 3 transitional cell carcinoma of the bladder.

Hara I, Miyake H, Takechi Y, Eto H, Gotoh A, Fujisawa M, Okada H, Arakawa S, Kamidono S; Kobe Urogenital Tumor Study Group..

Int J Urol. 2003 Jan;10(1):19-24.

12.

Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology.

Raman JD, Ng CK, Boorjian SA, Vaughan ED Jr, Sosa RE, Scherr DS.

BJU Int. 2005 Nov;96(7):1031-5.

13.

Chromosomal high-polysomies predict tumour progression in T1 transitional cell carcinoma of the bladder.

Ribal MJ, Alcaraz A, Mengual L, Carrio A, Lopez-Guillermo A, Mallofré C, Palou J, Gelabert A, Villavicencio H.

Eur Urol. 2004 May;45(5):593-9.

PMID:
15082201
14.

Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients.

Orsola A, Trias I, Raventós CX, Español I, Cecchini L, Búcar S, Salinas D, Orsola I.

Eur Urol. 2005 Aug;48(2):231-8; discussion 238.

PMID:
15963635
15.
16.

Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.

Lebret T, Bohin D, Kassardjian Z, Herve JM, Molinie V, Barre P, Lugagne PM, Botto H.

J Urol. 2000 Jan;163(1):63-7.

PMID:
10604315
17.

Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.

Kikuchi E, Fujimoto H, Mizutani Y, Okajima E, Koga H, Hinotsu S, Shinohara N, Oya M, Miki T; Cancer Registration Committee of the Japanese Urological Association..

Int J Urol. 2009 Mar;16(3):279-86. doi: 10.1111/j.1442-2042.2008.02235.x. Epub 2009 Jan 20.

18.

Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.

Tut VM, Braithwaite KL, Angus B, Neal DE, Lunec J, Mellon JK.

Br J Cancer. 2001 Jan;84(2):270-5.

19.

Bladder tumours in Chinese: a 6 year study.

Lam KY, Chan AC, Chan KW.

Aust N Z J Surg. 1994 Aug;64(8):551-5.

PMID:
8048894
20.

15-year experience on intravesical therapy of T1G3 urinary bladder cancer: a conservative approach.

Cheng CW, Chan SF, Chan LW, Chan CK, Ng CF, Cheung HY, Chan SY, Wong WS, Lai FM, Li ML.

Jpn J Clin Oncol. 2004 Apr;34(4):202-5.

PMID:
15121756

Supplemental Content

Support Center